George Zarkavelis Davide Mauri Fotini Karassa Kampletsas Eleftherios George Pentheroudakis Alexandra Pappadaki Leonidas Mavroeidis Panagiotis Ntellas Stefania Gkoura Ioanna Gazouli
10.5114/wo.2020.94727
Contemp Oncol (Pozn)
2020;24(1):75-78.
anti-tif-1γ autoimmune dermatomyositis immunotherapy ipilimumab nivolumab paraneoplastic urothelial cancer
CC BY-NC-SA
https://pubmed.ncbi.nlm.nih.gov/32514241/
Case Reports
PMC7265958
32514241
The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literature
2020